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Cytotoxm B of C dr#iclle was highly punfied by selective ammomum sulfate preclpitatlon, Blogel A5m chromatography, phenyl boronate hydro- 
phobic mteractlon chromatography and ultracentrifugatlon. The final cytotoxlc product had a specific actlvlty of 7.8 x 10s unitsimg protein and 
showed a single protein band with an estimated molecular weight of 163000 when subjected to SDS-PAGE. Immunoelectrophoresis of the final 
product shoned a single preclpltm arc The addltlon of cytotoxin B to lmidazole-HCl buffer (pH 7.4) containmg MgSO,, KC1 and the substrate 
2-phosphoglycerate resulted in the formatIon of phosphoenolpyruvate as demonstrated by spectrophotometric analysis. Phosphoglycerate conver- 
slon was absent when the cytotoxm was heat-macttvated of reacted with specific antitoxm prior to assay. 
Cytotosm: Enolase: 2.Phosphoglycerate 
1. INTRODUCTION 2. MATERIALS AND METHODS 
Clostridium difficile, the etiologic agent of 
pseudomembranous colitis and antibiotic-associated 
diarrhea [l-4], produces two exotoxins (A and B). 
Toxin A, an enterotoxin, induces intestinal fluid ac- 
cumulation in rabbit ligated ileal loops, an acute in- 
flammatory response, and hemorrhagic edema [S-8]. 
In contrast, toxin B does not induce intestinal fluid ac- 
cumulation but is a potent cytotoxin for numerous cell 
types [g-lo]. Various molecular masses, ranging from 
50 000 to 600 000, have been reported for cytotoxin B 
[5,1 l-l 31. These differences in molecular mass could be 
due to complex associations of a single peptide, en- 
zymatic cleavage of a protoxin( or the production of 
multiple forms. 
2.1. Culture conditrons 
C. diffiile MC201, obtamed from S.J. Booth (University of 
Nebraska Medical Center, Omaha), was used for toxin production. 
The organism was grown (37”C, 48 h) in a one-liter round-bottomed 
flask containing 500 ml supplemented peptone, as described [I 11. 
2.2. Toxm purlfrcation 
A cell-free filtrate (0.45 pm, Millipore) was concentrated 3-fold by 
YM-100 ultrafiltration (Amicon). After 75% saturation with am- 
monium sulfate, the precipitate was collected by centrifugation and 
suspended in 8 ml of cold 67 mM K-phosphate buffer (KPB; pH 7.5). 
The sample was fractionated on a 2.5 x 90 cm column of Biogel A5m 
(BioRad) and 8 ml fractions automatically collected. Cytotoxic frac- 
tions were pooled and concentrated on a YM-5 membrane (Amicon). 
Recently, Torres and Lonnroth [14] reported the 
presence of two forms of cytotoxin B produced by the 
same bacterial strain. In other studies Bisseret et al. [ 151 
attempted the purification of cytotoxin B, reporting a 
single homogeneous protein with a molecular mass of 
290 000. The protein had a molecular mass of 52 000 
under denaturing conditions. Comparison of the amino 
acid sequence of tryptic peptides of toxin B with se- 
quences of known proteins showed high similarities 
between the cytotoxin B peptides and enolases (EC 
4.2.1.11). The current studies were intiated to isolate 
and highly purify cytotoxin B by separate methods and, 
more importantly, to determine whether cytotoxin B 
had the ability to act as an enolase. 
The YM-5 retentate was applied to a phenyl boronate column 
(Amicon) and eluted uith a 100 mM D-ribose gradient. Cytotoxlc 
fractions were pooled, concentrated to 3.0 ml on a YM-5 ultrafiltra- 
tion membrane and separated on an 11 ml sucrose density gradient 
(I .134-1.149 g/ml). The gradient was cusluoned with 1 ml of 40% 
sucrose and completed at 205 000 x g for 48 h (4°C) in an IEC model 
B60 ultracentrifuge (SB282 rotor). The gradient was eluted and 
cytotoxic fractions dialyzed against 15 liters of 0.05 M KPB. Protein 
concentration was estimated by the method of Bohlen et al. [16]. 
2.3. Toxin assays 
Mouse Y 1 adrenal cells were used to determine the activity of 
cytotoxm 8, as described [9]. Cytotoxlc units were expressed as the 
reciprocal of the dilution which induced in excess of 9040 cell round- 
ing. The presence of enterotoxic activity was determined in the rabbit 
ligated ileal loop assay, as described [17]. 
2:.4. Sodium dodecyl sulfate polyacrylamide gel electrophoresis 
Samples were analysed in a vertical slab unit (BioRad) using a gel 
thickness of 0.75 mm and an acrylamide concentration of lo%, as 
described [18]. The gels were silver stained [19] and molecular masses 
determined by comparison to standard reference proteins. 
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;!.5. Immunoelectrophoresis (IEP) 
Samples were subjected to IEP in 2% Noble Agar, as described 
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Table I 
Summary of procedures for the isolation of Clostrrdrum drfficik cytotowin Ba 
Purification Biological Spectftc activtty Percent 
procedure acttvityb Protein (units/mg protein) yteld 
Cell-free filtrate 5x IO8 5200 mg 9.6 x 10” 100 
XM-100 concentrate 4X lo8 2880 mg 2.4 x 10s 80 
(NH.r)2SO~ precipitate 4x 10” 190 mg 2.1 x lo6 80 
Biogel A5m I x IO8 15 mg 6.7 x 10h 20 
Phenyl boronate lx IO8 7 mg 1.4x 10: 20 
Ultracentrifugation 7x 10’ 90 Pg 7.8 X 10” 14 
‘The standard devtation was less than 5% for all values; data represents cytotovic activity 
bData represent total recovery by each respective procedure 
[20]. Goat anttserum against C. dlfficrle culture filtrate was obtained 
from T.D. Wtlkins (VPI, Blacksburg, VA). 
2.6. Assay of enolase actrvrly 
Enolase activity was assayed by the spectrophotometric method of 
Warburg and Christtan [21], as descrtbed [22]. The reaction mixture 
consisted of 50 mM tmidazole-HCI buffer (pH 7.4) supplemented 
wtth 1 mM MgSOd, 400 mM KCI and 1 mM 2-phosphoglycerate. 
After enzyme addition, the rate of phosphoenolpyruvate production 
was measured at 240 nm using a Beckman DB/GT spectrophoto- 
meter; maxtmum absorption (240 nm) for phosphoenolpyruvate was 
determmed previously by scanning the product in a spectrophoto- 
meter. One umt of enzyme acttvity was defined as the amount 
required to convert 1 pmole of 2-phosphoglycerate to phosphoenol- 
pyruvate per minute. 
2.7. Phosphoenoip.vruvate formation 
The formation of phosphoenolpyruvate from 2-phosphoglycerate 
was determined by coupled enzymatic reacttons, using lactate 
dehydrogenase (EC 1.1.1.27) and pyruvate kinase (EC 2.7.1.40) 
Briefly, the reactton system contained final concentrations of 0.05 M 
imidazole-HCI buffer (pH 7.6) supplemented with 0.12 M KC1 and 
0.062 M MgSOd, 0.6 mM ADP, 0.18 mM NADH, 27 units lactate 
dehydrogenase, 3.9 units pyruvate kinase and I x 10’ units cytotoxm 
B in a fmal volume of 3.0 ml. After 5 mm for equilibration the reac- 
tion was initiated by the addition of 0.1 mM 2-phosphoglycerate. The 
decrease in optical denstty at 340 nm was observed as a measure of 
the formation of phosphoenolpyruvate as described (Boehringer 
Mannheim Biochemicals, Indianapolis, IN). Control reacttons were 
completed in the absence of cytotoxin B or 2-phosphoglycerate. 
2.8. Statlsrical anal_v.srs 
All calculations were performed with an IBM/PC using a 
PHARM/PCS version 3.0 (Microcomputer Specialists, Elkins Park, 
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Fig. 1. Biogel A5m molecular sieve chromatogram 
3. RESULTS AND DISCUSSION 
Cytotoxin B was highly purified by using ammonium 
sulfate precipitation, molecular sieve and hydrophobic 
interaction chromatography and sucrose density gra- 
dient ultracentrifugation (Table I). Culture cell-free 
filtrate was concentrated 3-fold by ultrafiltration and 
the proteins precipitated with ammonium sulfate. The 
resuspended precipitate was separated on a Biogel A5m 
column, resulting in a single protein peak at the column 
void volume and a bimodal peak during fractionation 
(Fig. 1). Toxic activity was located in the first portion 
of the bimodal peak. 
Pooled and concentrated toxic fractions from the 
Biogel A5m column were separated by hydrophobic in- 
teraction chromatography using phenyl boronate (Fig. 
2). Toxic activity was observed to elute in the apex of 
the absorption peak. All other fractions were void of 
toxic activity. Active fractions were then further 
separated by sucrose density gradient ultracentrifuga- 
tion (Fig. 3). Elution of the gradient revealed the 
presence of a biphasic absorption peak with toxic ac- 
tivity associated with the latter phase. This method 
resulted in an 8125fold increase in specific activity. 
Cytotoxin B (lo6 units) did not show enterotoxic activi- 
ty in the rabbit ligated ileal loop model or suckling in- 
fant mouse assay. 
Analysis of the final toxin sample by SDS-PAGE and 






Ftg. 2. Phenyl boronate hydrophobic interaction chromatogram. D- 
Rtbose concentratton is represented in mM. 
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Fig. 3. Sucrose density gradient ultraccntrrfugation elution profile. 0 2 4 6 
Sucrose density is represented in g/ml. 
TIME (MINUTES) 
single protein band with a molecular mass of 163 000 
(not shown) and a single precipitin arc, respectively 
(Fig. 4). These results on molecular mass are similar to 
a single subunit complex of the ‘form 2’ cytotoxin 
recently described by Torres and Lonnroth [14]. 
Variable differences in the molecular mass of cytotoxin 
B reported in the literature [l l-131 could be related to 
the association(s) of subunits. Additional studies are 
underway to determine the subunit composition of 
cytotoxin B. 
Fig. 5. Time course of enolase activity identified with Isolated 
cytotoxin B. No difference was observed between the control (buffer) , 
and enzyme reacted with heat or antitoxin. 
In further studies the final toxin sample showed an 
enzymatic activity similar to enolase (EC 4.2.1.11) 
from Saccharomyces cerivisiae. Using 2-phospho- 
glycerate as substrate, the rate of toxin-mediated phos- 
phoenolpyruvate formation was assessed spectrophoto- 
metrically at 240 nm (Fig. 5). As shown, cytotoxin B 
reacted similar to yeast enolase, resulting in an increase 
of phosphoenolpyruvate. The formation of phospho- 
enolpyruvate was confirmed by using the pyruvate 
kinase/lactate dehydrogenase nzyme system, which is 
coupled to the oxidation of NADH (Fig. 6). Under the 
stated conditions, cytotoxin B had an enolase activity 
of approximately 700 units per mg protein. The specific 
activities for chicken brain, chicken skeletal-muscle and 
human brain enolases are 85, 78 and 91 units per mg 
protein, respectively 123-251. The catalytic effect of 
0.80.- 0 
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Fig. 6. Formation of phosphoenolpyruvate by cytotoxin B. The 
reaction was coupled to pyruvate kinase/lactate dehydrogenase 
enzymes, resulting in the oxidation of NADH. 
cytotoxin B/enolase was inhibited by antitoxin and 
heat inactivation (Fig. 5). These results support the 
studies of Bisseret et al. [15] which indicate that the 
amino acid sequence of cytotoxin B is similar to 






Fig. 4. fmmunoelectrophoresis of C. dgfficile cytotoxin B fractionated by phenyl boronate hydrophobic interaction chromatography (A) and 
sucrose denstty gradient ultracentrifugation (B). 
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